Arrestin3 mediates D2 dopamine receptor internalization

Synapse

Volumn 63, Issue 7, 2009, Pages 621-624

  Skinbjerg, Mette ^a,b,c   Ariano, Marjorie A ^d   Thorsell, Annika ^e   Heilig, Markus ^e   Halldin, Christer ^c   Innis, Robert B ^b   Sibley, David R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Arrestin; D2 receptor; Internalization

Indexed keywords

2 METHOXY N PROPYLNORAPOMORPHINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ARRESTIN 2; ARRESTIN 3; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; ETICLOPRIDE; G PROTEIN COUPLED RECEPTOR; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; EPIFLUORESCENCE MICROSCOPE; INTERNALIZATION; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALS; ARRESTINS; BENZAZEPINES; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; NAPROXEN; NEURONS; RECEPTORS, DOPAMINE D2; SALICYLAMIDES;

EID: 67449107964     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20636     Document Type: Article

References (19)

1. 2 dopamine receptor distribution in the rodent CNS using anti-peptide antisera. Brain Res 609:71-80. (Pubitemid 23136803)
2. Ariano MA, Sortwell CE, Ray M, Altemus KL, Sibley DR, Levine MS. 1997. Agonist-induced morphologic decrease in cellular D1A dopamine receptor staining. Synapse 27:313-321. (Pubitemid 27479469)
3. Ariano MA, Wagle N, Grissell AE. 2005. Neuronal vulnerability in mouse models of Huntington's disease: Membrane channel protein changes. J Neurosci Res 80:634-645. (Pubitemid 40896184)
4. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. 2005. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261-273. (Pubitemid 41032989)
5. Bjork K, Rimondini R, Hansson AC, Terasmaa A, Hyytia P, Heilig M, Sommer WH. 2008. Modulation of voluntary ethanol consumption by beta-arrestin 2. FASEB J 22:2552-2560. (Pubitemid 351948672)
6. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. 1999. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495-2498. (Pubitemid 30026335)
7. 2 dopamine receptor mice. J Neurophysiol 85:659-670. (Pubitemid 32147768)
8. Ferguson SS. 2001. Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 53:1-24. (Pubitemid 32173106)
9. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. 2004. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107-144. (Pubitemid 39050399)
10. Ito K, Haga T, Lameh J, Sadee W. 1999. Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 260:112-119. (Pubitemid 29095701)
11. Kim KM, Valenzano KJ, Robinson SR, Yao WD, Barak LS, Caron MG. 2001. Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J Biol Chem 276:37409-37414. (Pubitemid 37384163)
12. Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ. 2001. beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci USA 98:1601-1606. (Pubitemid 32165545)
13. Lefkowitz RJ, Shenoy SK. 2005. Transduction of receptor signals by beta-arrestins. Science 308:512-517.
14. Macey TA, Gurevich VV, Neve KA. 2004. Preferential interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons. Mol Pharmacol 66:1635-1642. (Pubitemid 39564791)
15. McVittie LD, Ariano MA, Sibley DR. 1991. Characterization of anti-peptide antibodies for the localization of D2 dopamine receptors in rat striatum. Proc Natl Acad Sci USA 88:1441-1445. (Pubitemid 21916240)
16. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. 2000. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201-17210. (Pubitemid 30398969)
17. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. 2001. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis. J Biol Chem 276:19452-19460. (Pubitemid 37411282)
18. Seneca N, Zoghbi SS, Skinbjerg M, Liow JS, Hong J, Sibley DR, Pike VW, Halldin C, Innis RB. 2008. Occupancy of dopamine D(2/3) receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [(H)C] MNPA. Synapse 62:756-763.
19. Skinbjerg M, Namkung Y, Halldin C, Innis RB, Sibley DR. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's (MNPA) interactions with D2 and D3 dopamine receptors. Synapse (in press).